BioAge Labs (BIOA) Non-Current Debt (2023 - 2025)

BioAge Labs (BIOA) has 3 years of Non-Current Debt data on file, last reported at $1.1 million in Q1 2025.

• For the quarter ending Q1 2025, Non-Current Debt changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2025 stood at $1.1 million (changed N/A YoY), and the FY2024 full-year result was $2.5 million, down 69.49% from the prior year.
• Non-Current Debt declined to $1.1 million in Q1 2025, from $2.5 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $8.2 million in Q4 2023 to a low of $1.1 million in Q1 2025.
• A 3-year average of $3.9 million and a median of $3.2 million in 2024 frame the typical range for Non-Current Debt.
• Peak annual rise in Non-Current Debt reached 69.49% in 2024, while the deepest fall reached 69.49% in 2024.
• Tracing BIOA's Non-Current Debt over 3 years: stood at $8.2 million in 2023, then sank by 69.49% to $2.5 million in 2024, then plunged by 57.79% to $1.1 million in 2025.
• Business Quant data shows BIOA's Non-Current Debt at $1.1 million in Q1 2025, $2.5 million in Q4 2024, and $3.9 million in Q3 2024.